Agenda

Agenda: New Horizons in Biologics & Bioprocessing
 
Copenhagen, June 3
 

 

 
^{Note that changes to the agenda may occur. Any changes will be reflected here. Stay up to date by revisiting this page before the event.}

---

 

09.00                Registration, 1-2-1 meetings & networking in the exhibition hall

09.30                Welcome and Introduction

                                Morten Munk, Director Global Alliance Management, FUJIFILM Diosynth Biotechnologies

09.35                Aquaporins in Health and Disease

                                Karin Lindkvist, Professor, Lund University

10.00                Accelerating Industrialization of Biopharmaceuticals

                             Adam Wegelius, Bioprocessing Specialist and Researcher, Testa Center

10.25                To Be Announced Soon

                                

10.50                Coffee, 1-2-1 meetings & networking in the exhibition hall

11.30                Accelerating ATMP Innovations Through Proximity and Collaboration: The Flemingsberg Model

                                 Natasha Bank, Cluster Manager, Flemingsberg Science Foundation

11.55                Mitazalimab: A Novel Approach for Metastatic Pancreatic Cancer – Phase 2 Data and the Way to Registration Trials

                                 Søren Bregenholt, CEO, Alligator Bioscience

12.20                Lunch, 1-2-1 meetings & networking in the exhibition hall

13.15                To be announced soon

                                

13.40                From Discovery to Delivery: Charting the Path to a Crimean-Congo Hemmorhagic Fever Virus Vaccine

                                 Ali Mirazimi, Professor, Karolinska Institutet

14.05                Establishing State-of-the-Art CAR T Cell Manufacturing Capabilities in a Newly Established Not-for-Profit Organization in Sweden

                                 Chao Sheng, PhD, Process Development Manager & Team Lead, CCRM Nordic

14.30                Curing Incurable Diseases with Cell Therapy 

                                 Anna Falk, Professor in Stem Cells, Lund University

14.55                Coffee, 1-2-1 meetings & networking in the exhibition hall

15.30                Impact of Virus-Caused Diseases on Public Health and Society: Access to Countermeasures and Preparedness Against Disease X

                                  Niklas Arnberg, Professor in Virology, Umeå University
                                  & Secretaty General, Virus- and Pandemic Foundation

15.55                Innovating Snakebite Diagnostics: Towards Accessible, Rapid Solutions

                                  Jonas Jürgensen, CEO and Co-founder, VenomAid Diagnostics

16.20                Summary & Conclusion

                                  Morten Munk, Director Global Alliance Management, FUJIFILM Diosynth Biotechnologies

16.25                End of agenda